November 17, 2016
The Ministry of Health, Labor and Welfare (MHLW) will add 10 active pharmaceutical ingredients (APIs)/17 products, approved with minor changes to existing products, to the NHI reimbursement price list on November 18, including new dosages for Humira (adalimumab). Humira, AbbVie’s...read more